Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To your point, it appears some big titan news releases have been...for lack of a better word...suppressed. Neither the Zaring nor the design freeze press releases made it on to the TMDI news tab in TD Ameritrade, one of the largest trading platforms. Why? I see so many tiny tiny nothingburger press releases day in and day out...that merely mention a stock is a mover that day. But huge news like those don't make it...very odd. I emailed the TMDI customer service email about it and have not heard back. This makes me think the theory about SP purposely being held down may have some truth to it.
Good find, old chum
Poor mangement is no grounds for a suit
For a r&d firm the best fiducial duty they can fulfill is to get the robot to market...whatever that takes. May decimate sp in the process. They don't have a legal or other responsibilty to deliver a specific share price, that's part of the risk the owners take on when investing.
Thank you ...yes there should be IP. I have not checked, what if anything is out there for medtronics robot in terms of IP?
Let us also not forget Fowler moving to KS, who Medtronic recently announced is their optics partner for their robot. And thus the circle is complete.
The evidence favors Medtronic over JnJ at this point
At the risk of sounding cynical maybe he was fired?
You don't think that would be part of their confidential robot program?
I've also asked and not received any response. Chad was VP of robotics so he would've known. And it's true medtronic would have an iron clad non-compete so it only logically follows if TMDI is part of the picture.
Its because of the news they are selling off autolap...not sure what that was anyway. Also some company is investing $30million at $2 per share. Let us know when they have a robot that's worth a hoot. Until then Glg is right dead cat
I agree with your assessment especially now that Chad is on board...not proof but seems very coincidental.
But would covidien? They also sell ligation clips/appliers.
Brilliant annalysis thank you!
Additionally not all news makes it to TD ameritrade...design freeze and appointment of Chad are both not posted under TMDI news section. Could be a glitch but c'mon...
How did JnJ partner with Titan and not require they use Ethicon ligation clips/ appliers? The only way that could be reconciled is if the clips are that much different but I believe JnJ makes a functionally equivalent clip to teleflex.
Yes but also because they see somthing there...they are making it happen, cap'n
Good thought...we tend to view TMDI robot as ASC niche but could it be a more attractive option in hospitals due to the potential cost and time reduction over davinci. However, admins would have to be very dense to ditch such a huge capital and marketable investment off the bat. I could see TMDI replacing davincis once they are end of life and only if it covers the same scope of procedures for a cost savings.
Please tell the market
If this is correct, why would JnJ have not required TMDI to use their ligation clips/appliers? I can't reconcile how TMDI would go off and partner w/teleflex in that scenario...?
Interesting case study. Obvious product differences aside I'd like to point out a difference in product positioning - there are already dozens of hemostatic agents on the market and it's only getting more crowded. It probably had clinicians asking "what's the need?". Late to the game and not a good value proposition. Which brings me to another thought - that could be a similar risk Titan is facing. Obviously we are much later to the game than we would've preferred...the novelty has worn off especially with SP on the market. But external to TMDI a lot of leaders are questioning the value of robotic surgery in a host of applications ...prostatectomy, hysterectomy etc...the data is starting to show its more expensive and time consuming than regular lap surgery and the results are not necessarily better. We take for granted the "robotic surgery is the future" truism, but what if it's not? Or maybe it is but just different than how we currently think about robotic surgery. Perhaps we are currently in a lull and the second wave of robots will be tidal when they hit shore....kind of how davinci was around a while and met moderate success, then it skyrocketed. Who knows. All I know I learned in clown school.
The hiring of Rad Chad suggests they are formulating the sales strategy so it can be executed immediately upon commercialization. I think it wise to get ahead on this. Before you criticize the timing, remember talent doesn't grow on trees...they likely had to snatch him when they could, even though I would not agree that his acquisition was premature.
But this doesn't rule out Titan outsourcing something to Verb.
Here's a puzzler...covidien and jnj both make ligation clips and appliers...if Titan were partnering with either of the bigs why would they partner with teleflex for clip appliers? This tells me Titan is NOT partnering with Medtronic or JnJ.
Medtronic and JnJ are mortal enemies no way they would both get in bed together, each would demand exclusivity with titan as a partner.
It depends on how they structure it. 51% is effectively 100% ownership. They could buy part with deliverables to achieve full contract, use convertible debt instruments, options, on and on... I am no expert in M&A, maybe someone here is and can offer deeper insight.
I admit news has akways had a strange and backwards effect on TMDI's share price. Im also hopeful that we continue to see the trend of a more normal cause and effect, something that appears to be hapening slowly over time. One day pinnochio will be a real boy.
Huuuuugggweeeeee!
Would be awesome if we had more clarity on this. At least to know the status of human cases.
While we didn't close in your estimated range we landed above it from after hours trading. Do you know news is coming monday? What do you know?
The next milestone is completion of GLP animal studies, slated to have been completed end of H1 2019. If they announced such, it could be a jump start to sp. Then human cases which I anticipate will take longer than the 6 months they have estimated on the timeline. Unless the 3 COE already have things lined up and all they have to do is schedule the patients, but not likely...IRB etc takes time
It took Mako many years of going it alone with sales before they were bought out. They were the first and only orthopedic surgery robot. I don't agree the fact we have not been bought out signifies the robot is not going anywhere.
This man speaketh the truth:
https://m.nasdaq.com/symbol/tmdi/after-hours
No evidence at all...
https://vimeo.com/user50119475
Looks like it may be mostly short volume today...
https://volumebot.com/?s=tmdi
Could be my man - here's to hoping!
Good gravy it was a satirical post. Do I normally make such egregious grammatical errors?
If you are effectively managing your portfolio what should your beta be?
Your analysis is emotional, based on your bitterness at your poor investment decision. don't lecture on investing agnosticism. Can you tell me how to calculate TMDI's beta and what it means within the next minute (without having to google it)? If not, you have no business telling anyone what investing is.